|
SH3RF1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.8351101728249E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.20180018451322E-10 |
| Normal-vs-Stage2 |
4.313500000519E-07 |
| Normal-vs-Stage3 |
2.82969999987337E-07 |
| Normal-vs-Stage4 |
4.49860000000246E-05 |
| Stage1-vs-Stage2 |
3.376600E-01 |
| Stage1-vs-Stage3 |
5.506600E-01 |
| Stage1-vs-Stage4 |
3.067600E-01 |
| Stage2-vs-Stage3 |
6.684000E-01 |
| Stage2-vs-Stage4 |
7.269400E-01 |
| Stage3-vs-Stage4 |
5.068800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.04180006235788E-11 |
| Normal-vs-AfricanAmerican |
2.37409999992444E-07 |
| Normal-vs-Asian |
2.020100E-04 |
| Caucasian-vs-AfricanAmerican |
8.730400E-01 |
| Caucasian-vs-Asian |
1.289370E-01 |
| AfricanAmerican-vs-Asian |
1.625250E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.64865906984824E-12 |
| Normal-vs-Female |
3.34270000013071E-07 |
| Male-vs-Female |
3.921400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.06360000041006E-07 |
| Normal-vs-Extreme_Weight |
2.05889749693711E-11 |
| Normal-vs-Obese |
1.0201000000265E-07 |
| Normal-vs-Extreme_Obese |
8.922300E-03 |
| Normal_Weight-vs-Extreme_Weight |
8.554000E-01 |
| Normal_Weight-vs-Obese |
7.676600E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.075800E-01 |
| Extreme_Weight-vs-Obese |
4.953200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.201600E-01 |
| Obese-vs-Extreme_Obese |
4.835200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.648900E-04 |
| Normal-vs-Age(41-60Yrs) |
3.51840001577841E-10 |
| Normal-vs-Age(61-80Yrs) |
1.64140034897287E-10 |
| Normal-vs-Age(81-100Yrs) |
2.039300E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.051000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.137000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.627200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.769200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.138200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.081200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.68061137123732E-12 |
| Normal-VS-Type2 PRCC |
5.38809999950374E-08 |
| Normal-VS-KIRP CIMP |
4.623600E-04 |
| Normal-VS-Unclassified PRCC |
8.4379999999995E-05 |
| Type1 PRCC-VS-Type2 PRCC |
7.310800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.993600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.670600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.918800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.865000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.483200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.16080042747535E-10 |
| Normal-vs-N1 |
4.48020000000104E-05 |
| Normal-vs-N2 |
3.091500E-02 |
| N0-vs-N1 |
2.029400E-01 |
| N0-vs-N2 |
6.221400E-01 |
| N1-vs-N2 |
9.131200E-01 |
|
|
